P2B-088

State Health Centre Oncology Department (Budapest, Hungary) › P2B-088

P2B-088

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
State Health Centre Oncology Department (Budapest, Hungary) · Dr. Clarke
consented 2013-03-16

withdrawn

AEs

1

Serious

0

Dropout signal

–

Adverse events

1

Grade 3 anaemia with onset in cycle 2 (2013-05-08); assessed as related to study drug (probable); resolved 2013-06-17; action: drug interrupted.

severe assessed

Data queries

0

No data queries. Open queries would appear here for this patient.